Stéphane Besse

IOHEXOL PLASMA CLEARANCE IN HEALTHY DOGS AND CATS

Isabelle Goy‐Thollot, CAROLINE CHAFOTTE, Stéphane Besse et al. · Veterinary Radiology & Ultrasound · 2006 · 38 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17

Development of an Ecofriendly Anticoagulant Rodenticide Based on the Stereochemistry of Difenacoum

Marlène Damin‐Pernik, Bernadette España, Stéphane Besse et al. · Drug Metabolism and Disposition · 2016 · 38 citations · Full text

Veterinary Medicine, Pharmacokinetics, Toxicology +15

New insights into the catalytic mechanism of vitamin K epoxide reductase (VKORC1) – The catalytic properties of the major mutations of rVKORC1 explain the biological cost associated to mutations

Benjamin Matagrin, Ahmed Hodroge, Adrien Montagut-Romans et al. · FEBS Open Bio · 2013 · 31 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Comparative inhibitory effect of prenylated coumarins, ferulenol and ferprenin, contained in the ‘poisonous chemotype’ of Ferula communis on mammal liver microsomal VKORC1 activity

Marie-Sophie Louvet, G. Gault, Sébastien Lefebvre et al. · Phytochemistry · 2015 · 29 citations · Full text

Medicine, Biochemistry, Pharmacology +8

Simplified Methods for Estimation of Plasma Clearance of Iohexol in Dogs and Cats

Isabelle Goy‐Thollot, Stéphane Besse, François Garnier et al. · Journal of Veterinary Internal Medicine · 2006 · 26 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17